Your Notifications
All done, no notifications

What is Esophageal Cancer?

Esophageal cancer is a malignant tumor that develops in the esophagus, the muscular tube that carries food from the mouth to the stomach. The two main types are esophageal squamous cell carcinoma, which develops from the cells lining the esophagus, and esophageal adenocarcinoma, which develops from glandular cells and is often associated with the lower esophagus.

What is the Importance of Timely Treatment?

Early diagnosis and treatment of esophageal cancer are important because the disease can progress and spread without treatment. When detected earlier, treatment is more likely to control or eliminate the cancer.

Timely evaluation can also help determine whether surgery, chemotherapy, radiotherapy, immunotherapy, targeted therapy, or a combination of treatments is most appropriate. For advanced disease, treatment may focus on controlling cancer growth, relieving symptoms, maintaining nutrition, and improving quality of life.

What are the Common Symptoms of Esophageal Cancer?

  • Difficulty or pain while swallowing
  • A feeling that food is getting stuck in the throat or chest
  • Progressive difficulty swallowing solid and liquid foods
  • Unexplained weight loss
  • Chest or upper abdominal discomfort
  • Persistent indigestion or heartburn
  • Regurgitation of food
  • Persistent cough or hoarseness
  • Nausea or vomiting
  • Fatigue or weakness
  • Gastrointestinal bleeding, which may cause vomiting of blood or black stools

Causes and Risk Factors of Esophageal Cancer

Causes

  • Esophageal cancer develops when genetic and molecular changes cause cells in the esophageal lining to grow uncontrollably. The exact mechanisms vary by tumour type.
  • Long-term exposure to certain risk factors can drive cellular changes that increase cancer risk.

Risk Factors

  • Increasing age
  • Tobacco use
  • Heavy alcohol consumption
  • Long-standing gastroesophageal reflux disease (GERD)
  • Barrett's esophagus
  • Obesity, particularly for adenocarcinoma
  • Certain dietary patterns and nutritional deficiencies
  • Achalasia and other long-standing esophageal disorders
  • Previous exposure to certain caustic substances
  • Family history or inherited susceptibility in selected cases

Latest Research and Technologies in the Treatment of Esophageal Cancer in the United Arab Emirates

  • Treatment of esophageal cancer is advancing through improvements in precision staging, minimally invasive surgery, radiotherapy, immunotherapy, and molecular testing. Minimally invasive and robotic esophagectomy can reduce surgical trauma in appropriate patients. Advanced radiotherapy techniques, including IMRT and image-guided radiotherapy, help deliver radiation more precisely. Immunotherapy with immune checkpoint inhibitors and biomarker-guided treatment is increasingly used for selected locally advanced or metastatic cancers.

Treatment options for Esophageal Cancer

Endoscopic treatment: Early, superficial cancers and selected precancerous lesions may be treated using endoscopic mucosal resection or endoscopic submucosal dissection.

Esophagectomy : It may be performed to remove the affected portion of the esophagus and nearby lymph nodes. Minimally invasive or robotic approaches may be appropriate for selected patients.

Chemotherapy : Chemotherapy may be used before surgery, after surgery, together with radiotherapy, or for advanced disease.

Chemoradiotherapy: Combined chemotherapy and radiation may be used for locally advanced disease or when surgery is not appropriate.

Immunotherapy : Immune checkpoint inhibitors may be considered for selected advanced or recurrent cancers based on tumour characteristics and previous treatment.

Targeted therapy : Targeted medicines may be used for cancers with specific biomarkers, such as HER2-positive disease.

  • Clinical assessment:
    • Evaluation: A detailed medical history and physical examination, including assessment of swallowing difficulties, weight loss, reflux symptoms, tobacco and alcohol exposure, nutritional status, and general health.
    • Upper gastrointestinal endoscopy: Allows direct examination of the esophagus and identification of abnormal areas.
    • Endoscopic biopsy: Obtains tissue samples to confirm cancer and determine its histological type.
    • Pathology and biomarker testing: May assess tumour type and biomarkers, including mismatch repair and microsatellite instability, when relevant to treatment planning.
  • Imaging Tests:
    • CT scan: Helps assess the primary tumour, lymph nodes, and possible spread to other organs.
    • PET/CT: Can help detect metabolically active disease and assess distant metastases in appropriate patients.
    • Endoscopic ultrasound (EUS): Helps evaluate tumour invasion depth and nearby lymph nodes.
    • MRI: May be used in selected cases when detailed imaging of specific areas is required.
    • Bronchoscopy: May be considered for selected upper or middle esophageal tumours when involvement of the airway is suspected.

MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive tele-rehabilitation services designed to support Esophageal Cancer patients in the United Arab Emirates. These services include:

  • Swallowing therapy: Speech and swallowing specialists may help patients safely regain or improve swallowing function.
  • Physical rehabilitation: Physiotherapy and gradual exercise can help restore strength, mobility, and endurance after treatment.
  • Respiratory rehabilitation: Breathing exercises may be helpful after major thoracic or upper gastrointestinal surgery.
  • Medicines used for esophageal cancer depend on the stage, tumour type, biomarker profile, and treatment plan. Immunotherapy, including immune checkpoint inhibitors, may be appropriate for selected advanced or recurrent cancers. Targeted therapy, such as HER2-directed treatment, may be considered when the tumour has the relevant biomarker. Supportive medicines may also be used to manage pain, nausea, reflux, nutritional problems, and treatment-related side effects.

Instantly Connect with our Specialists

Doctor 1
Doctor 2
Doctor 3
Doctor 4
Doctor 5
Doctor 6
Doctor 7
Doctor 8

Hospitals for Esophageal Cancer in United Arab Emirates

Thumbay University Hospital, Ajman: Top Doctors, and Reviews
Thumbay University Hospital, Ajman

Ajman, United Arab Emirates

Thumbay University Hospital, Ajman located in Ajman, United Arab Emirates is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

  • The hospital has a 250 bed capacity.
  • Excellent quality of healthcare facilities and services at par with developed countries.
  • Multilingual and multinational healthcare professionals working in the Thumbay Hospital Ajman (belonging to 20 nations and fluent in 50 plus languages).
  • Equipped with the newest facilities to ensure highest standards of healthcare delivery to patients at economical costs.
  • Dedicated, compassionate and highly educated healthcare professionals work in Thumbay Hospital Ajman.
  • Well developed diagnostic facilities are also available.
  • A 24/7 functioning emergency care department and advanced facilities in Radiology.
  • There is presence of an ultramodern Catheterization Lab (Cath Lab) and Electrosurgery Cryotherapy in dermatology, Interlocking intramedullary nailing.
  • Also available under dental departments Panoramic, digital intra-oral X-rays, Cephalogram are present.
  • Some of the important specialties in Thumbay Hospital Ajman are:
    • Ear, nose, and throat
    • Cardiovascular
    • Bariatric surgery
    • General surgery
    • Urology
    • Nephrology

Message Us

253

PROCEDURE

40

DOCTORS IN 14 SPECIALITIES

13+

FACILITIES & AMENITIES

Our Services to better your experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Why Choose the United Arab Emirates for Esophageal Cancer Treatment?

  • Experienced cancer specialists: Surgical oncologists, medical oncologists, radiation oncologists, gastroenterologists, and other specialists can contribute to treatment planning.
  • Advanced diagnostic facilities: Endoscopy, biopsy, EUS, PET/CT, CT imaging, and molecular or biomarker testing can support accurate staging and treatment selection.
  • Multidisciplinary cancer care: Treatment can involve surgeons, oncologists, radiologists, pathologists, gastroenterologists, nutritionists, and rehabilitation specialists.
  • Modern treatment technologies: Eligible patients may have access to minimally invasive and robotic surgery, advanced radiotherapy, chemotherapy, immunotherapy, and targeted treatments.
  • International patient support: Many major hospitals provide dedicated services for international patients, including medical coordination, documentation, accommodation, travel assistance, and follow-up planning.

Frequently Asked Questions

Recovery from esophageal cancer varies according to the cancer stage, treatment received, and the patient's overall health. Recovery after esophagectomy may take several weeks to months, and eating patterns, swallowing, and nutritional needs may take longer to stabilise. During recovery, nutritional support, swallowing therapy, and physical rehabilitation may be needed.

Yes. Most patients with esophageal cancer can walk and remain physically active when their health permits. Activity may need to be adjusted according to fatigue, nutritional status, treatment side effects, surgery, and medical advice.

Many specialised UAE cancer centres provide advanced diagnostic and treatment facilities, including endoscopy, PET/CT, EUS, minimally invasive and robotic surgery, IMRT, chemotherapy, immunotherapy, and biomarker-based treatment. Availability varies by hospital and depends on individual patient eligibility.

Many major UAE hospitals have dedicated international patient departments that assist with medical appointments, treatment coordination, travel documentation, accommodation, interpretation, and follow-up arrangements.

Consider a centre with experienced esophageal or gastrointestinal cancer specialists, advanced diagnostic facilities, surgical and oncology services, multidisciplinary tumour-board care, nutritional support, and rehabilitation services. For advanced disease, also consider access to relevant immunotherapy, targeted therapy, and clinical-trial options when appropriate.

There is no single success rate for esophageal cancer. Outcomes depend on the cancer stage, tumour type, location, lymph-node involvement, overall health, treatment approach, and response to therapy. Early-stage disease generally has different treatment outcomes from locally advanced or metastatic disease.

the United Arab Emirates has specialised cancer centres with surgical, medical, and radiation oncologists experienced in treating gastrointestinal cancers, including esophageal cancer. Patients should review the specialist's experience, the hospital's cancer services, surgical facilities, and access to multidisciplinary care.

Treatment-related risks depend on the procedure, medicines used, tumour location, and the patient's overall health. Esophagectomy may cause complications such as bleeding, infection, respiratory problems, leakage at the surgical connection, or difficulties with eating and nutrition. Chemotherapy may cause nausea, fatigue, low blood counts, and an increased risk of infection. Radiotherapy may cause oesophagal inflammation, painful swallowing, fatigue, and other site-specific effects. Immunotherapy can cause inflammatory reactions affecting organs such as the lungs, liver, bowel, or thyroid. Targeted medicines also have potential adverse effects

Consult a multidisciplinary cancer team to confirm the diagnosis, establish the stage, and discuss suitable treatment options. Review the biopsy findings, imaging results, tumour type, relevant biomarker tests, nutritional status, and the expected benefits and risks of each recommended treatment.Seek urgent medical assessment if you cannot swallow liquids, have significant bleeding, develop severe breathing difficulties, or experience signs of dehydration. Do not delay evaluation if swallowing difficulties persist or worsen.

Esophageal cancer does not typically cause external physical deformities. However, the cancer or its treatment may lead to long-term changes in swallowing, eating patterns, digestion, body weight, nutritional status, or physical stamina. Some patients may require ongoing dietary adjustments, nutritional support, or rehabilitation.

Yes. Difficulty swallowing, weight loss, fatigue, pain, treatment side effects, nutritional problems, and emotional stress can significantly affect quality of life. Nutritional care, swallowing therapy, physical rehabilitation, symptom management, and psychological support can help address these challenges.

Yes. Untreated esophageal cancer can continue to grow and may spread to nearby lymph nodes or distant organs. Progressive disease can cause severe swallowing difficulties, malnutrition, bleeding, pain, airway or other organ involvement, and other serious complications.

Esophageal cancer cannot always be prevented, but certain measures may reduce risk. Avoid tobacco, limit or avoid alcohol, maintain a healthy weight, and seek medical advice for persistent reflux symptoms or difficulty swallowing.People with Barrett's esophagus or other recognised high-risk conditions should follow their clinician's recommendations for monitoring and surveillance. These measures can reduce some risks or help detect relevant abnormalities; they cannot guarantee prevention.

Yes. The risk of Esophageal cancer increases with age and varies according to cancer type and geographic population. Tobacco and heavy alcohol use are important risk factors for squamous cell carcinoma, while long-standing GERD, Barrett's oesophagus, and obesity are associated with an increased risk of adenocarcinoma. Men are also affected more frequently than women overall.

Author

Fauzia Zeb Fatima
Fauzia Zeb Fatima

M.Pharm

4 Years of Experience

Fauzia Zeb is a distinguished medical and scientific content writer with a robust academic foundation in pharmaceutical sciences, holding a B.Pharm and M.Pharm degree from prestigious institutions, including MIT and Jamia Hamdard University. Her comprehensive expertise in pharmacology, clinical sciences, and biomedical research enables her to translate complex medical and scientific concepts into precise, evidence-based content tailored for diverse audiences. Specializing in peer-reviewed articles, clinical blog posts, and research-driven publications, she demonstrates a consistent ability to bridge the gap between advanced medical science and accessible, audience-specific communication. View More

Reviewer

Dr. Mohit Agarwal
Dr. Mohit Agarwal

Medical Oncologist

14 Years of Experience

One of the finest Oncologist in New Delhi, India, Dr. Mohit Agarwal has worked with several world class multidisciplinary hospitals over the years. Dr. Mohit Agarwal has over 14+ years of experience in his field. The doctor treats and manages a wide range of conditions such as Stomach Cancer, Rectal Cancer, Breast Cancer, Brain Cancer View More

Last Reviewed - January 2026